VAP vs. Routine Test
Only the VAP cholesterol Test achieves the new NCEP ATP III Guidelines objective
to improve patient risk assessment and promote more aggressive therapy.
The Routine Cholesterol test information can only account for approximately 45% of
cholesterol abnormalities, the VAP patient profile identifies up to 90%.
| NCEP ATP III Guidelines |
VAP Cholesterol Test |
Routine Cholesterol Profile |
| Total Cholesterol
|
YES
|
YES
|
| HDL
|
YES
|
YES
|
| LDL
|
YES (directly measured, using "gold standard" ultracentrifugation)
|
YES (calculated)
|
| Triglycerides
|
YES
|
YES
|
| Non-HDL Cholesterol (LDL + VLDL)
|
YES
|
NO
|
| Metabolic Syndrome
|
YES
|
NO
|
| Lp(a)
|
YES
|
NO
|
| LDL Pattern Size
|
YES
|
NO
|
| Atherogenic Remnant Lipids (IDL + VLDL)
|
YES
|
NO
|